Activation of Vascular Endothelial Growth Factor A Transcription in Tumorigenic Glioblastoma Cell Lines by an Enhancer with Cell Type-specific DNase I Accessibility
Open Access
- 1 May 2002
- journal article
- Published by Elsevier
- Vol. 277 (22) , 20087-20094
- https://doi.org/10.1074/jbc.m201766200
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomasHistopathology, 2001
- VEGF: an update on biological and therapeutic aspectsCurrent Opinion in Biotechnology, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- Antiangiogenic Gene Therapy in a Rat Glioma Model Using a Dominant-Negative Vascular Endothelial Growth Factor Receptor 2Human Gene Therapy, 1999
- Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawalProceedings of the National Academy of Sciences, 1997
- Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibodyProceedings of the National Academy of Sciences, 1996
- Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.Proceedings of the National Academy of Sciences, 1996
- Angiogenesis in malignant gliomasGlia, 1995
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantNature, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993